Donghui Zhou

Qingchun Road 79
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

PD-L1 splice variant-driven soluble PD-L1 secretion promotes immune evasion in gastric cancer.

PD-L1 splice variant-driven soluble PD-L1 secretion promotes immune evasion in gastric cancer.

Journal: International journal of biological macromolecules

Published: August 30, 2025

AC129507.1 is a ferroptosis-related target identified by a novel mitochondria-related lncRNA signature that is involved in the tumor immune microenvironment in gastric cancer.

AC129507.1 is a ferroptosis-related target identified by a novel mitochondria-related lncRNA signature that is involved in the tumor immune microenvironment in gastric cancer.

Journal: Journal of translational medicine

Published: August 29, 2024

CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing.

CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing.

Journal: Cancer letters

Published: August 14, 2024

The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer.

The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer.

Journal: Heliyon

Published: November 22, 2023

MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation.

MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 05, 2023

Development and evaluation of the Newstage system: integrating tumor regression grade and lymph node status for improved prognostication in neoadjuvant treatment of gastric cancer.

Development and evaluation of the Newstage system: integrating tumor regression grade and lymph node status for improved prognostication in neoadjuvant treatment of gastric cancer.

Journal: World journal of surgical oncology

Published: September 25, 2023

Stem cell landscape aids in tumor microenvironment identification and selection of therapeutic agents in gastric cancer.

Stem cell landscape aids in tumor microenvironment identification and selection of therapeutic agents in gastric cancer.

Journal: Cellular signalling

Published: July 23, 2023

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study.

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study.

Journal: Journal for immunotherapy of cancer

Published: February 14, 2022

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.

Journal: International journal of biological sciences

Published: January 26, 2022

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: February 07, 2021

The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.

The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR.

Journal: Experimental and therapeutic medicine

Published: September 25, 2020

Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.

Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.

Journal: Nature communications

Published: August 21, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026